Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients-Reference-Cited by-同舟云学术

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

Published:2020-12-16 Issue:6 Volume:87 Page:2602-2613
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Moort Iris¹^ORCID,Preijers Tim²^ORCID,Hazendonk Hendrika C.A.M.¹,Schutgens Roger E.G.³^ORCID,Laros‐van Gorkom Britta A.P.⁴,Nieuwenhuizen Laurens⁵,Meer Felix J.M.⁶,Fijnvandraat Karin⁷⁸^ORCID,Leebeek Frank W.G.⁹^ORCID,Meijer Karina¹⁰^ORCID,Mathôt Ron A.A.²,Cnossen Marjon H.¹^ORCID,

Affiliation:

1. Department of Pediatric Hematology Erasmus University Medical Center ‐ Sophia Children's Hospital Rotterdam The Netherlands

2. Department of Clinical Pharmacology ‐ Hospital Pharmacy Amsterdam University Medical Centers The Netherlands

3. Van Creveldkliniek University Medical Center Utrecht, University Utrecht Utrecht The Netherlands

4. Department of Thrombosis and Hemostasis Radboud university medical center Nijmegen The Netherlands

5. Department of Thrombosis and Hemostasis Maxima Medical Center Veldhoven The Netherlands

6. Department of Thrombosis and Hemostasis Leiden University Medical Center Leiden The Netherlands

7. Department of Pediatric Hematology Amsterdam University Medical Centers Amsterdam The Netherlands

8. Department of Molecular and Cellular Hemostasis Sanquin Research Amsterdam the Netherlands

9. Department of Hematology Erasmus University Medical Center Rotterdam the Netherlands

10. Department of Hematology University Medical Center Groningen Groningen The Netherlands

Funder

Baxalta

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14670

Reference27 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

2. Guidelines for the management of hemophilia

3. Diagnosis and management of haemophilia

4. Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years

5. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement;Clinical Pharmacology & Therapeutics;2024-02-19

2. Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling;CPT: Pharmacometrics & Systems Pharmacology;2022-06-24

3. Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?;Hematology;2021-12-10

4. Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice;Blood Advances;2021-10-26

5. Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia;BMJ Case Reports;2021-04